Lonza Expands UK Mammalian Production

Swiss fine and specialty chemicals producer Lonza has expanded its mammalian production capacity to meet increased demand for biopharmaceutical development and clinical manufacturing services.

Two 1,000 liter single-use bioreactors have been added to its site in Slough, UK, the company’s center of excellent for development and clinical supply, significantly increasing capacity.

Lonza said the new reactors, equipped with controllers that enable parallel operations and expanded process capabilities with flexible operating scales and bioreactor types, complement existing single-use equipment for both seed train systems and downstream processing, including chromatography, filtration and ultrafiltration unit operations.

The company added that the technologies support its ability to accommodate a variety of customer projects and processes across scales and clinical phases.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

most read